Who owns ADMA BIOLOGICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ADMA from SEC Form 13F filings across 321 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 321 institutions disclosed 203.2M shares of ADMA BIOLOGICS, INC. worth $1.70B — about 89% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
321
13F holders
$1.70B
value, 2026 filers
89%
of shares outstanding (203.2M sh)
53
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ADMA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 38.4M | $321.0M | 0.0% | 16.8% | +4.1% |
| 2 | STATE STREET CORP | 17.1M | $143.3M | 0.0% | 7.5% | +21.5% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 10.1M | $84.6M | 0.0% | 4.4% | -2.0% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 10.1M | $84.4M | 0.0% | 4.4% | +13.8% |
| 5 | Rubric Capital Management LP | 9.3M | $78.2M | 0.7% | 4.1% | +416.2% |
| 6 | Capital Research Global Investors | 8.8M | $73.3M | 0.0% | 3.8% | -21.8% |
| 7 | FIRST TRUST ADVISORS LP | 7.8M | $65.3M | 0.0% | 3.4% | +2064.9% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 6.1M | $50.7M | 0.0% | 2.7% | +4.0% |
| 9 | Caligan Partners LP | 5.7M | $47.9M | 2.3% | 2.5% | +20.4% |
| 10 | D. E. Shaw & Co., Inc. | 5.3M | $44.1M | 0.0% | 2.3% | +840.5% |
| 11 | DIMENSIONAL FUND ADVISORS LP | 3.6M | $30.2M | 0.0% | 1.6% | -28.0% |
| 12 | GOLDMAN SACHS GROUP INC | 3.5M | $29.4M | 0.0% | 1.5% | +25.3% |
| 13 | B Group, Inc. | 3.3M | $27.3M | 12.8% | 1.4% | +1.7% |
| 14 | Nuveen, LLC | 3.3M | $27.3M | 0.0% | 1.4% | -46.5% |
| 15 | Duquesne Family Office LLC | 2.8M | $23.3M | 0.4% | 1.2% | +80.1% |
| 16 | NORTHERN TRUST CORP | 2.4M | $20.2M | 0.0% | 1.1% | +6.1% |
| 17 | Nantahala Capital Management, LLCNEW | 2.4M | $19.8M | 0.7% | 1% | new |
| 18 | MORGAN STANLEY | 2.3M | $19.0M | 0.0% | 1% | -6.9% |
| 19 | Ranger Investment Management, L.P. | 2.1M | $17.7M | 1.1% | 0.9% | -7.4% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | $17.5M | 0.0% | 0.9% | -0.2% |
| 21 | TWO SIGMA INVESTMENTS, LP | 2.0M | $16.9M | 0.0% | 0.9% | -3.5% |
| 22 | KENNEDY CAPITAL MANAGEMENT LLC | 1.8M | $14.7M | 0.3% | 0.8% | +326.7% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 1.7M | $13.8M | 0.0% | 0.7% | +1.0% |
| 24 | Fundsmith LLP | 1.6M | $13.8M | 0.1% | 0.7% | 0.0% |
| 25 | BANK OF AMERICA CORP /DE/ | 1.6M | $13.8M | 0.0% | 0.7% | -58.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.